Hims & Hers Health, Inc. (HIMS)财务
NYSE · Healthcare · Medical - Care Facilities · 员工2,442人 · CEO Andrew Dudum
- 股价
- $27.68 -6.71%
- 市值
- $62.3亿
- 企业价值
- $71.6亿
- 最近财报
- Q2 '26 2026-08-10提交
- 下次财报
- 2026-11-09 EPS预期 $0.06
营收(TTM)$25.8亿+28.0% 对比去年同期最近4个季度;柱状图=各季度
营业利润率(TTM)-3.6%-9.8 百分点 对比去年同期营业利润 -$9270万
净利润(TTM)-$1.42亿-173.4% 对比去年同期税后,含营业外收益
自由现金流(TTM)$8990万-24.8% 对比去年同期资本支出 $1.77亿
稀释EPS(TTM)-$0.63-178.3% 对比去年同期最近4个季度之和
净现金-$7.05亿-803.6% 对比去年同期现金 + 短期投资 - 债务
估值与关键数据
- 市值
- $62.3亿 EV $71.6亿
- 营收
- $25.8亿 过去12个月
- 营收增速
- +37% FY2026年一致预期
- 净利润率
- -5.5% 净利润 / 营收,TTM
- P/E
- -45.4× 预期 -47.0×(FY2026)
- P/S
- 2.4× 股价 / 营收,TTM
- EV / EBITDA
- -93.7× TTM
- 自由现金流
- $8990万 过去12个月
- 净利润
- -$1.42亿 过去12个月
- 营收预期
- $32.1亿 FY2026年一致预期
- 盈利
- 2026-11-09 营收预期 $8.93亿
- 股息
- – 无股息
核心要点
根据披露数据计算,每条结论都附有其依据的数字。
- 最近财报(2026-08-10):营收超预期7.8%,EPS 低于预期643.1%营收$7.53亿,预期$6.99亿(+7.8%);EPS -$0.37,预期-$0.05(-643.1%)。
- 营收增长平稳:同比38.2%Q2 '26营收$7.53亿,此前四个季度的平均值为38.5%。
- 营业利润率-3.6%(TTM),较去年同期-9.8 百分点营收增长28.0%,营业利润增长-173.8%。
- 资本支出占营收的6.9%(去年为7.1%)最近4个季度投入$1.77亿(同比+24.5%)。自由现金流$8990万。
- 股东回报$1.13亿 = 自由现金流的125.8%回购$1.13亿(去年为$3500万),股息$0,股权激励$1.54亿(TTM)。 超过自由现金流:由现金储备或举债支付。
- 稀释股数一年内减少9.7%Q2 '26稀释股数2.32亿,一年前为2.57亿。
- 净债务 $7.05亿现金 + 短期投资 $8.41亿,含租赁债务 $15.5亿;一年前净现金 $1亿。
上一季度:Q2 '26
截至2026-06-30的季度。与去年同期及财报发布前的分析师一致预期对比。
本季度与去年同期
| Q2 '26 | 去年同期 | 变化 | |
|---|---|---|---|
| 营收 | $7.53亿 | $5.45亿 | +38.2% |
| 毛利率 | 63.8% | 76.4% | -12.6 百分点 |
| 营业利润 | -$9720万 | $2670万 | -463.7% |
| 营业利润率 | -12.9% | 4.9% | -17.8 百分点 |
| 净利润 | -$8630万 | $4250万 | -303.0% |
| 稀释EPS | -$0.37 | $0.17 | -317.6% |
| 经营现金流 | -$3590万 | -$1910万 | -88.0% |
| 资本支出 | $1940万 | $5030万 | -61.4% |
| 自由现金流 | -$5540万 | -$6940万 | +20.2% |
| R&D | $0 | $3780万 | -100.0% |
| 股权激励费用 | $4210万 | $3570万 | +17.9% |
实际 vs 一致预期
2026-08-10| 实际 | 一致预期 | 对比预期 | |
|---|---|---|---|
| 营收 | $7.53亿 | $6.99亿 | +7.8% |
| EPS(一致预期口径) | -$0.37 | -$0.05 | -643.1% |
来自2026-08-10发布的Q2 '26财报：营收及分析师预期口径的EPS（通常为调整后），可能与上方报表中的EPS不同。
EPS与一致预期
最近8次财报营收
收入从何而来,按业务线和地区逐季展示。
营收、营业利润与增速
季度按地区划分的营收
占总额比例| 分部 | Q2 '26 | 同比 | 占比 | TTM | TTM同比 | 12个季度 |
|---|---|---|---|---|---|---|
| United States | $6.22亿 | – | 82.6% | – | – | |
| Non-US | $1.31亿 | – | 17.4% | – | – |
利润率与成本结构
每一单位营收在各层级还剩多少,成本又花在哪里。
利润率
季度成本占营收比例
季度现金流与资本配置
创造了多少现金,用在何处,又有多少回到股东手中。
经营现金流、资本支出、自由现金流
季度现金用途与经营现金流
财年最近4个季度
现金流量表- 经营现金流
- $2.67亿
- 资本支出
- -$1.77亿
- 股票回购
- -$1.13亿
- 股息
- $0
- 收购
- -$4.58亿
- 债务净发行
- $3.87亿
- 股权激励费用
- $1.54亿
- 自由现金流
- $8990万
- 股东回报 / FCF
- 125.8%
股数与EPS
季度,稀释资产负债表
各季度末的流动性、投资和债务。
现金、投资与债务
季度末估值与回报
当前估值倍数与公司自身过去五个财年对比;分析师目标价与评级。
估值倍数与回报
TTM与过去5个财年| 当前 | 5年均值 | 当前处于5年区间的位置 | |
|---|---|---|---|
| P/E(TTM) | -45.4× | 49.3× 5年中的2年 | 41.7× – 57.0× |
| EV / EBITDA | -93.7× | 51.2× 5年中的2年 | 45.9× – 56.4× |
| EV / 营收 | 2.8× | 3.1× | 2.0× – 4.3× |
| 股价 / FCF | 69.3× | 54.9× 5年中的3年 | 26.3× – 98.8× |
| 股价 / 净资产 | 19.8× | 7.5× | 3.7× – 13.5× |
| FCF收益率 | 1.4% | 0.3% | -3.2% – 3.8% |
| 投入资本回报率 | -3.7% | -8.7% | -32.6% – 12.7% |
| 净资产收益率 | -30.0% | -2.0% | -32.2% – 26.4% |
分析师
一致目标价 $32.17 (+16.2%)
区间 $24.50 – $42.00 · 评级 Hold
强烈买入0
买入7
持有13
卖出0
强烈卖出0
展望
分析师对未来财年的一致预期,以及按当前股价意味着什么。
一致预期
| 财年 | 营收 | 增速 | EPS | 增速 | 按当前股价的P/E | 分析师(EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $32.1亿 | +36.6% | -$0.59 | -215.5% | -47.0× | 8 |
| FY2027 | $40.5亿 | +26.1% | $0.30 | +150.6% | 92.8× | 9 |
| FY2028 | $46亿 | +13.8% | $0.69 | +131.9% | 40.0× | 7 |
| FY2029 | $49.8亿 | +8.0% | $0.78 | +13.2% | 35.3× | 2 |
| FY2030 | $46.4亿 | -6.7% | $0.85 | +8.5% | 32.6× | 4 |
财务报表
利润表、资产负债表和现金流量表的每一项,含12个季度和10个财年,以金额、占营收比例或增速展示。
全部披露项目
Hims & Hers Health, Inc.在近期10-Q / 10-K文件中标记的全部252项数据,附SEC官方标签和定义,包括附注(租赁、税务、回购、员工等)。
| 项目(SEC标签) | 最近季度 | 去年同期 | 同比 | 最近财年 | 上一财年 | 同比 |
|---|---|---|---|---|---|---|
| Accounts Payable, Current | $5.01亿 | $1.05亿 | +377.4% | $1.43亿 | $9120万 | +57.1% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $3210万2025-12-31 | $610万 | +426.2% | $3210万 | $610万 | +426.2% |
| Accounts Receivable, Allowance for Credit Loss, Current | $02025-12-31 | $0 | – | $0 | $0 | – |
| Accounts Receivable, Allowance for Credit Loss, Writeoff | – | – | – | $0 | $0 | – |
| Accretion (Amortization) of Discounts and Premiums, Investments | $9.6万 | $36.7万 | -73.8% | $203万 | $436万 | -53.3% |
| Accrued Liabilities, Current | $2.1亿 | $6570万 | +220.2% | $7850万 | $5300万 | +48.1% |
| Accrued Marketing Costs, Current | $2600万 | $1400万 | +85.2% | $1670万 | $2180万 | -23.3% |
| Accrued Professional Fees, Current | $3230万 | $1220万 | +164.2% | $986万 | $846万 | +16.5% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $7120万 | $3660万 | +94.2% | $5260万 | $2450万 | +114.7% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$4600万 | $82.2万 | -5,700.6% | $229万 | -$32.4万 | +808.0% |
| Additional Paid in Capital, Common Stock | $6.62亿 | $7.12亿 | -7.0% | $6.52亿 | $7.19亿 | -9.3% |
| Amortization of Debt Issuance Costs and Discounts | $196万 | $105万 | +86.7% | $453万 | $0 | – |
| Amortization of Intangible Assets | $1870万 | $280万 | +567.9% | $2370万 | $380万 | +523.7% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $4440万 | $3670万 | +21.0% | $1.39亿 | $9460万 | +46.7% |
| Assets | $36.3亿 | $18.8亿 | +93.3% | $21.5亿 | $7.08亿 | +204.5% |
| Assets, Current | $13.8亿 | $13.6亿 | +2.1% | $7.68亿 | $3.96亿 | +93.9% |
| Assets, Fair Value Disclosure | $4.4亿 | – | – | $8.22亿 | $1.45亿 | +465.9% |
| Business Combination, Contingent Consideration, Liability, Current | $365万2025-12-31 | $0 | – | $365万 | $0 | – |
| Capital Expenditures Incurred but Not yet Paid | $784万 | $594万 | +32.1% | $2520万 | $778万 | +224.4% |
| Cash and Cash Equivalents, at Carrying Value | $6.1亿 | $11.2亿 | -45.8% | $2.29亿 | $2.21亿 | +3.6% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $6.1亿 | $11.2亿 | -45.8% | $2.29亿 | $2.21亿 | +3.2% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $3.88亿 | $8.5亿 | -54.4% | $718万 | $1.24亿 | -94.2% |
| Common Stock, Value, Issued | $2.3万 | $2.3万 | 0.0% | $2.3万 | $2.2万 | +4.5% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | -$1.28亿 | $4350万 | -394.1% | $1.31亿 | $1.26亿 | +4.1% |
| Contract with Customer, Liability, Current | $1.41亿 | $9840万 | +43.7% | $1.27亿 | $7530万 | +68.9% |
| Convertible Debt, Noncurrent | $13.7亿 | $9.69亿 | +40.8% | $9.73亿 | $0 | – |
| Cost of Revenue | $2.72亿 | $1.29亿 | +111.8% | $6.14亿 | $3.03亿 | +102.5% |
| Current Federal Tax Expense (Benefit) | – | – | – | -$3.4万 | $164万 | -102.1% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $563万 | $0 | – |
| Current Income Tax Expense (Benefit) | – | – | – | $852万 | $732万 | +16.4% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $293万 | $568万 | -48.5% |
| Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | $0 | -$38.4万 | +100.0% | – | – | – |
| Debt Securities, Available-for-sale | $2.84亿2025-09-30 | $8860万 | +220.7% | $7970万2024-12-31 | $1.24亿 | -35.9% |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | $19.4万2025-09-30 | $24.7万 | -21.5% | $12.4万2024-12-31 | $4.3万 | +188.4% |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | $1.9万2025-09-30 | $0 | – | $10002024-12-31 | $1.5万 | -93.3% |
| Debt Securities, Available-for-sale, Amortized Cost | $2.84亿2025-09-30 | $8830万 | +221.4% | $7950万2024-12-31 | $1.24亿 | -36.0% |
| Debt Securities, Available-for-sale, Amortized Cost, Current | $2.32亿 | – | – | $3.48亿 | $7950万 | +338.0% |
| Debt Securities, Available-for-sale, Amortized Cost, Noncurrent | $3.5亿2025-12-31 | – | – | $3.5亿 | – | – |
| Debt Securities, Available-for-sale, Current | $2.31亿 | $2000万 | +1,054.3% | $3.49亿 | $7970万 | +337.9% |
| Debt Securities, Available-for-sale, Noncurrent | $0 | – | – | $3.51亿 | $0 | – |
| Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain | $60.5万2025-09-30 | – | – | – | – | – |
| Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss | $13万2025-09-30 | – | – | – | – | – |
| Debt Securities, Held-to-maturity, Fair Value | $4.38亿2025-09-30 | – | – | – | – | – |
| DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss | $4.38亿2025-09-30 | – | – | – | – | – |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | -$459万 | -$4330万 | +89.4% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | -$621万 | $0 | – |
| Deferred Income Tax Assets, Net | $1.12亿 | $8420万 | +32.5% | $8270万 | $6160万 | +34.3% |
| Deferred Income Tax Expense (Benefit) | -$936万 | -$946万 | +1.0% | -$1300万 | -$6160万 | +79.0% |
| Deferred Income Tax Liabilities, Net | $3090万 | – | – | $2890万 | $0 | – |
| Deferred Revenue | $1.19亿2025-09-30 | – | – | $7530万2024-12-31 | $770万 | +877.9% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | -$216万 | -$1830万 | +88.2% |
| Deferred Tax Assets, Goodwill and Intangible Assets | $899万2025-12-31 | $27.6万 | +3,155.8% | $899万 | $27.6万 | +3,155.8% |
| Deferred Tax Assets, Gross | $1.47亿2025-12-31 | $7710万 | +90.1% | $1.47亿 | $7710万 | +90.1% |
| Deferred Tax Assets, Inventory | $584万2025-12-31 | $587万 | -0.5% | $584万 | $587万 | -0.5% |
| Deferred Tax Assets, Net | $5390万2025-12-31 | $6160万 | -12.6% | $5390万 | $6160万 | -12.6% |
| Deferred Tax Assets, Net of Valuation Allowance | $1.43亿2025-12-31 | $7460万 | +91.2% | $1.43亿 | $7460万 | +91.2% |
| Deferred Tax Assets, Operating Loss Carryforwards | $1930万2025-12-31 | $2100万 | -8.4% | $1930万 | $2100万 | -8.4% |
| Deferred Tax Assets, Operating Loss Carryforwards, Domestic | $2630万2025-12-31 | $6080万 | -56.7% | $2630万 | $6080万 | -56.7% |
| Deferred Tax Assets, Operating Loss Carryforwards, Foreign | $3140万2025-12-31 | $990万 | +217.2% | $3140万 | $990万 | +217.2% |
| Deferred Tax Assets, Operating Loss Carryforwards, State and Local | $8370万2025-12-31 | $9720万 | -13.9% | $8370万 | $9720万 | -13.9% |
来源:SEC companyfacts(每份10-Q / 10-K的XBRL)。现金流量表的季度数据由10-Q标记的年初至今累计数推算。分部拆分带有维度标记,在分部章节中单独展示。
数据来源
报表、分部营收、指标和预期均根据公司文件标准化。分部利润及全部披露项目:SEC EDGAR(XBRL)。 已读取的文件: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
数据截至 2026-11-02